Showing results (141-150 of 5,967) with videos related to
Sort By:
Pageof 597
European Heart Journal|August 9, 2022
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudyPaul M Ridker, Katherine R Tuttle, Vlado Perkovic, et al.Kidney International|November 8, 2025
From progression to remission: a new paradigm for success in chronic kidney diseaseNavdeep Tangri, Brendon L Neuen, David Z Cherney, et al.Substance and Alcohol Actions/Misuse|January 1, 1984
A rapid, quantitative in vivo assay for narcotic antagonistsM J Katovich, J W Simpkins, I C Song, et al.Drug and Alcohol Dependence Reports|March 25, 2024
Evaluation of peer recovery services for substance use disorder in Minnesota: Impact of peer recovery initiation on SUD treatment and recoveryCody R Tuttle, Aaron T Berger, Sean L Barton, et al.Clinical Kidney Journal|April 16, 2025
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trialsEmma R Webster, Adam Perkovic, Brendon L Neuen, et al.Journal of Clinical Microbiology|September 29, 2017
Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized PatientsD Nikolic, S S Richter, K Asamoto, et al.Diabetes|January 23, 2019
Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney DiseaseRadica Z Alicic, Joshua J Neumiller, Emily J Johnson, et al.Trends in Endocrinology and Metabolism: TEM|September 18, 2010
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptorEric M Jacobson, Eric R Hugo, Traci R Tuttle, et al.Anesthesiology|July 1, 1995
Computer-controlled epidural infusion to targeted cerebrospinal fluid concentrations in humans. ClonidineJ C Eisenach, D D Hood, R Tuttle, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibitionD D Hood, K A Mallak, R L James, et al.Pageof 597